시장보고서

상품코드

1681247

세계의 CTLA-4 억제제 시장(2025-2029년)

Global CTLA4 Inhibitors Market 2025-2029

발행일: 2025년 02월 | 리서치사:

TechNavio | 페이지 정보: 영문 204 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

CTLA-4 억제제 시장은 2024-2029년 19.1%의 연평균 복합 성장률(CAGR)로 35억 2,000만 달러 증가할 것으로 예측됩니다.

CTLA-4 억제제(CTLA-4 inhibitor) 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

CTLA-4 억제제의 높은 표적 친화성과 특이성, 병용요법의 인기 증가, CTLA-4 억제제 개발의 전략적 제휴 등이 시장을 주도하고 있는 CTLA-4 억제제 시장의 현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다.

시장 범위
기준 연도	2025년
종료 연도	2029년
예측 기간	2025-2029년
성장 모멘텀	가속
YOY 2025	15.6%
CAGR	19.1%
증가액	35억 2,000만 달러

이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.

본 조사에서는 향후 몇 년간 CTLA-4 억제제 시장의 성장을 가속하는 주요 이유 중 하나로 CTLA4의 연구 적응증 확대를 꼽고 있습니다. 또한, CTLA-4 억제제의 특효약 지정과 암에 대한 인식 증가는 시장의 큰 수요로 이어질 것입니다.

지역별 세분화
지역별 비교
북미 : 시장 규모와 예측(2024-2029년)
유럽 : 시장 규모와 예측(2024-2029년)
아시아 : 시장 규모와 예측(2024-2029년)
세계 기타 지역 : 시장 규모와 예측(2024-2029년)
미국 : 시장 규모와 예측(2024-2029년)
캐나다 : 시장 규모와 예측(2024-2029년)
독일 : 시장 규모와 예측(2024-2029년)
영국 : 시장 규모와 예측(2024-2029년)
프랑스 : 시장 규모와 예측(2024-2029년)
중국 : 시장 규모와 예측(2024-2029년)
일본 : 시장 규모와 예측(2024-2029년)
이탈리아 : 시장 규모와 예측(2024-2029년)
인도 : 시장 규모와 예측(2024-2029년)
네덜란드 : 시장 규모와 예측(2024-2029년)
시장 기회 : 지역 상황별

제13장 성장 촉진요인, 과제, 기회 및 성장 억제요인

시장 성장 촉진요인
시장이 해결해야 할 과제
성장 촉진요인과 과제의 영향
시장 기회와 성장 억제요인

제14장 경쟁 구도

개요
경쟁 구도
혼란 상황
업계 리스크

제15장 경쟁 분석

기업 개요
기업 순위 지수
기업의 시장 포지셔닝
Agenus Inc.
Akeso Inc.
AstraZeneca Plc
Bio Techne Corp.
BioNTech SE
Bristol Myers Squibb Co.
HBM Holdings Ltd.
Innovent Biologics Inc.
Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Merck and Co. Inc.
Ono Pharmaceutical Co. Ltd.
Shanghai Fosun Pharmaceutical Group Co. Ltd.
Xencor Inc.

제16장 부록

LSH 25.04.18

The CTLA4 inhibitors market is forecasted to grow by USD 3500.2 million during 2024-2029, accelerating at a CAGR of 19.1% during the forecast period. The report on the CTLA4 inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high target affinity and specificity of CTLA4 inhibitors, growing popularity of combination therapy, and strategic alliances in developing CTLA4 inhibitors.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	15.6%
CAGR	19.1%
Incremental Value	$3500.2 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's CTLA4 inhibitors market is segmented as below:

By Type

Monotherapy
Combination therapy

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Route Of Administration

Intravenous
Subcutaneous

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the expansion of research indications of CTLA4 as one of the prime reasons driving the CTLA4 inhibitors market growth during the next few years. Also, special drug designations of CTLA4 inhibitors and increasing awareness about cancer will lead to sizable demand in the market.

The report on the CTLA4 inhibitors market covers the following areas:

CTLA4 Inhibitors Market sizing
CTLA4 Inhibitors Market forecast
CTLA4 Inhibitors Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ctla4 inhibitors market vendors that include Agenus Inc., Akeso Inc., AstraZeneca PLC, Bio Techne Corp., BioNTech SE, Bristol Myers Squibb Co., HBM Holdings Ltd., Innovent Biologics Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., and Xencor Inc.. Also, the CTLA4 inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global CTLA4 Inhibitors Market 2019 - 2023
- Historic Market Size - Data Table on Global CTLA4 Inhibitors Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
8.3 Monotherapy - Market size and forecast 2024-2029
- Chart on Monotherapy - Market size and forecast 2024-2029 ($ million)
- Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million)
- Chart on Monotherapy - Year-over-year growth 2024-2029 (%)
- Data Table on Monotherapy - Year-over-year growth 2024-2029 (%)
8.4 Combination therapy - Market size and forecast 2024-2029
- Chart on Combination therapy - Market size and forecast 2024-2029 ($ million)
- Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million)
- Chart on Combination therapy - Year-over-year growth 2024-2029 (%)
- Data Table on Combination therapy - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
9.3 Hospital pharmacies - Market size and forecast 2024-2029
- Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online pharmacies - Market size and forecast 2024-2029
- Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Route of Administration

10.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
10.3 Intravenous - Market size and forecast 2024-2029
- Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
- Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
- Chart on Intravenous - Year-over-year growth 2024-2029 (%)
- Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
10.4 Subcutaneous - Market size and forecast 2024-2029
- Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
- Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.13 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Agenus Inc.
- Agenus Inc. - Overview
- Agenus Inc. - Product / Service
- Agenus Inc. - Key offerings
- SWOT
15.5 Akeso Inc.
- Akeso Inc. - Overview
- Akeso Inc. - Product / Service
- Akeso Inc. - Key offerings
- SWOT
15.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
15.7 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
- SWOT
15.8 BioNTech SE
- BioNTech SE - Overview
- BioNTech SE - Product / Service
- BioNTech SE - Key offerings
- SWOT
15.9 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
15.10 HBM Holdings Ltd.
- HBM Holdings Ltd. - Overview
- HBM Holdings Ltd. - Product / Service
- HBM Holdings Ltd. - Key offerings
- SWOT
15.11 Innovent Biologics Inc.
- Innovent Biologics Inc. - Overview
- Innovent Biologics Inc. - Product / Service
- Innovent Biologics Inc. - Key offerings
- SWOT
15.12 Jiangsu Hengrui Pharmaceuticals Co. Ltd.
- Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
- Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
- Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
- SWOT
15.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
15.14 Ono Pharmaceutical Co. Ltd.
- Ono Pharmaceutical Co. Ltd. - Overview
- Ono Pharmaceutical Co. Ltd. - Product / Service
- Ono Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.15 Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Shanghai Fosun Pharmaceutical Group Co. Ltd. - Overview
- Shanghai Fosun Pharmaceutical Group Co. Ltd. - Business segments
- Shanghai Fosun Pharmaceutical Group Co. Ltd. - Key offerings
- Shanghai Fosun Pharmaceutical Group Co. Ltd. - Segment focus
- SWOT
15.16 Xencor Inc.
- Xencor Inc. - Overview
- Xencor Inc. - Product / Service
- Xencor Inc. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

세계의 CTLA-4 억제제 시장(2025-2029년)

Global CTLA4 Inhibitors Market 2025-2029

목차

제1장 주요 요약

제2장 Technavio 분석

제3장 시장 구도

제4장 시장 규모

제5장 시장 규모 실적

제6장 정성 분석

제7장 Five Forces 분석

제8장 시장 세분화 : 유형별

제9장 시장 세분화 : 유통 채널별

제10장 시장 세분화 : 투여 경로별

제11장 고객 상황

제12장 지역별 상황